Detalhe da pesquisa
1.
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.
Haematologica
; 95(6): 914-21, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20015886
2.
KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
Mol Immunol
; 45(13): 3631-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18555529
3.
Differences between the different conditioning regimens for allogeneic stem cell transplantation.
Curr Opin Oncol
; 18(6): 667-70, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16988592
4.
The origin of epithelial neoplasms after allogeneic stem cell transplantation.
Haematologica
; 91(2): 283-4, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461326
5.
Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
Haematologica
; 90(10): 1339-45, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16219570
6.
A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.
Leuk Lymphoma
; 47(6): 1188-90, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16840222
7.
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.
Blood
; 111(5): 2581-8, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172005
8.
Cellular adoptive immunotherapy after allogeneic stem cell transplantation.
Curr Opin Oncol
; 17(6): 617-21, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16224243
9.
The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups.
Br J Haematol
; 123(1): 81-9, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14510946